Utilizing precision medicine to treat alcohol use disorder: A commentary on the α1 receptor antagonist

Alcohol Clin Exp Res (Hoboken). 2023 Mar;47(3):432-434. doi: 10.1111/acer.15014. Epub 2023 Feb 28.

Author

Carolina L Haass-Koffler^{1

2

3

4}

Affiliations

¹ Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
² Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, Rhode Island, USA.
³ Center for Alcohol and Addiction Studies, Brown University, Providence, Rhode Island, USA.
⁴ Carney Institute for Brain Science, Brown University, Providence, Rhode Island, USA.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Comment

MeSH terms

Adrenergic alpha-1 Receptor Antagonists
Alcohol Drinking
Alcoholism* / drug therapy
Humans
Precision Medicine

Substances

Adrenergic alpha-1 Receptor Antagonists

Grants and funding